Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (71-80 of 536) with videos related to

Pageof 54
Sort By:
Hematological Oncology|November 12, 2021
Immunophenotype of acute lymphoblastic leukemia in minorities- analysis from the SEER databaseElisa Quiroz, Aparajit Ram Venkateswaran, Rebecca Nelson, et al.
Bone Marrow Transplantation|May 16, 2019
Favorable outcomes for allogeneic hematopoietic cell transplantation in elderly patients with NPM1-mutated and FLT3-ITD-negative acute myeloid leukemiaIbrahim Aldoss, Ryotaro Nakamura, Dongyun Yang, et al.
American Journal of Hematology|February 1, 2021
Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agentsTamer A Othman, Matthew Mei, Jianying Zhang, et al.
The Journal of Biological Chemistry|April 26, 2011
Purification, identification, and cloning of lysoplasmalogenase, the enzyme that catalyzes hydrolysis of the vinyl ether bond of lysoplasmalogenLai-Chu Wu, Douglas R Pfeiffer, Elisabeth A Calhoon, et al.
Leukemia Research|April 8, 2021
Efficacy of blinatumomab for MRD relapse in ALL post allogenic HCTHaris Ali, Amandeep Salhotra, Anthony S Stein, et al.
Leukemia Research|June 25, 2017
Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemiaBijender Kumar, Arjun Kalvala, Su Chu, et al.
Journal of the American Society for Mass Spectrometry|December 31, 2003
Differential expression of histone post-translational modifications in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometryLiwen Zhang, Michael A Freitas, Joseph Wickham, et al.
Leukemia & Lymphoma|March 20, 2020
The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvementSalman Otoukesh, Jianying Zhang, Ryotaro Nakamura, et al.
Bone Marrow Transplantation|February 23, 2022
Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent IbrutinibShukaib Arslan, Haris Ali, Mathew Mei, et al.
Cancer|April 2, 2011
Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profilingViolaine Havelange, Nicole Stauffer, Catherine C E Heaphy, et al.
Pageof 54

Showing results (71-80 of 536) with videos related to

Sort By:
Pageof 54
Hematological Oncology|November 12, 2021
Immunophenotype of acute lymphoblastic leukemia in minorities- analysis from the SEER databaseElisa Quiroz, Aparajit Ram Venkateswaran, Rebecca Nelson, et al.
Bone Marrow Transplantation|May 16, 2019
Favorable outcomes for allogeneic hematopoietic cell transplantation in elderly patients with NPM1-mutated and FLT3-ITD-negative acute myeloid leukemiaIbrahim Aldoss, Ryotaro Nakamura, Dongyun Yang, et al.
American Journal of Hematology|February 1, 2021
Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agentsTamer A Othman, Matthew Mei, Jianying Zhang, et al.
The Journal of Biological Chemistry|April 26, 2011
Purification, identification, and cloning of lysoplasmalogenase, the enzyme that catalyzes hydrolysis of the vinyl ether bond of lysoplasmalogenLai-Chu Wu, Douglas R Pfeiffer, Elisabeth A Calhoon, et al.
Leukemia Research|April 8, 2021
Efficacy of blinatumomab for MRD relapse in ALL post allogenic HCTHaris Ali, Amandeep Salhotra, Anthony S Stein, et al.
Leukemia Research|June 25, 2017
Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemiaBijender Kumar, Arjun Kalvala, Su Chu, et al.
Journal of the American Society for Mass Spectrometry|December 31, 2003
Differential expression of histone post-translational modifications in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometryLiwen Zhang, Michael A Freitas, Joseph Wickham, et al.
Leukemia & Lymphoma|March 20, 2020
The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvementSalman Otoukesh, Jianying Zhang, Ryotaro Nakamura, et al.
Bone Marrow Transplantation|February 23, 2022
Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent IbrutinibShukaib Arslan, Haris Ali, Mathew Mei, et al.
Cancer|April 2, 2011
Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profilingViolaine Havelange, Nicole Stauffer, Catherine C E Heaphy, et al.
Pageof 54